Non-alcoholic Fatty Liver Disease and Its Association With Left Ventricular Diastolic Dysfunction: A Systematic

Namra V Gohil1,2, Nida Tanveer2,3, Vijaya Krishna Makkena2,4

  • 1Internal Medicine, Medical College Baroda, Vadodara, IND.

Cureus
|September 7, 2023
PubMed

Insights

Non-alcoholic fatty liver disease (NAFLD) is linked to heart problems like left ventricular diastolic dysfunction (LVDD). Early NAFLD treatment may prevent future cardiac complications in patients.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is a global health concern affecting multiple organs.
  • NAFLD is associated with cardiac remodeling and impaired left ventricular function.
  • Existing research on the NAFLD-left ventricular diastolic dysfunction (LVDD) link presents conflicting findings.

Purpose of the Study:

  • To systematically review and synthesize evidence on the association between NAFLD and LVDD.
  • To explore this relationship across diverse patient populations.
  • To clarify the connection between NAFLD and cardiac diastolic dysfunction.

Main Methods:

  • Conducted a systematic literature search of major medical databases (2003-2023).
  • Included 13 studies (9 cross-sectional, 3 reviews, 1 meta-analysis) involving 13,341 NAFLD patients.
  • Performed critical appraisal and qualitative synthesis of extracted data.

Main Results:

  • A significant association was identified between NAFLD and LVDD.
  • The review analyzed the relationship in various patient subgroups.
  • Consistent evidence points to an increased risk of cardiac dysfunction in NAFLD patients.

Conclusions:

  • NAFLD is significantly associated with LVDD.
  • Early intervention in NAFLD patients is crucial for preventing cardiac complications.
  • This systematic review highlights the importance of addressing NAFLD to mitigate cardiovascular risks.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15